Essayer OR - Gratuit
Senores Pharma eyes US injectables market
Mint Ahmedabad
|January 14, 2025
Newly-listed Senores Pharmaceuticals aims to set up a new facility in the US to make injectables, and eyes a larger pie of government contracts and controlled substance orders through partnerships with larger drugmakers in the country, a top company official said.
The Ahmedabad-based company, which has a presence in regulated markets like the US, the UK and Canada, as well as in emerging markets, has generics formulations as well as contract manufacturing and development businesses.
On 30 December, Senores Pharma's shares listed on the National Stock Exchange at ₹600, a premium of more than 53% over the issue price of ₹391. Its initial public offering closed on 24 December, after getting subscribed a massive 93.41 times. The IPO included a fresh issue of ₹500 crore and an offer for sale of ₹82.1 crore.
The company's stock fell nearly 13% to end at ₹439 on the NSE on Monday.
Cette histoire est tirée de l'édition January 14, 2025 de Mint Ahmedabad.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Ahmedabad
Mint Ahmedabad
Adobe nears $1.9 billion deal to buy Semrush
Adobe Inc. is nearing a deal to buy the marketing software company Semrush Holdings Inc. for $1.9 billion, The Wall Street Journal reported, a takeover that would mark its first since the failed $20 billion acquisition of Figma Inc. in 2022.
1 min
November 20, 2025
Mint Ahmedabad
RP-Sanjiv Goenka enters luxe fashion with FSP stake buy
PSG Ventures Ltd, part of the RP-Sanjiv Goenka Group, on Wednesday approved the acquisition of a 40% stake in FSP Design Pvt. Ltd, the company behind the luxury fashion label Falguni Shane Peacock (FSP), is marking its formal entry into India’s luxury apparel and lifestyle market.
1 mins
November 20, 2025
Mint Ahmedabad
India Inc's rural engine sputters in Q2
rural-linked firms grew slower than the rest of India Inc (comprising 2,753 companies), which posted a 6% revenue expansion in Q2.
2 mins
November 20, 2025
Mint Ahmedabad
Siemens must reignite growth
Siemens India Ltd’s stock is down 7% in this year so far, sharply underperforming the S&P BSE Capital Goods index, which continues to deliver positive returns. A sluggish revival in private capital expenditure and muted government spending have weighed on sentiment.
2 mins
November 20, 2025
Mint Ahmedabad
India seeks vessels to ship West Asia crude
A surge in bookings for oil tankers to bring cargoes from West Asia to India points to higher import flows ahead, as sanctions on major Russian producers force the South Asian importer to seek alternatives.
1 min
November 20, 2025
Mint Ahmedabad
OIL, Total partner for ultra-deep exploration
State-run Oil India Ltd (OIL) and French energy major TotalEnergies have joined hands to explore deep and ultra-deepwater offshore basins in the country.
1 min
November 20, 2025
Mint Ahmedabad
Meta's big court win
Social media major Meta has won big relief as a US judge ruled in its favour in an antitrust case filed by the US Federal Trade Commission (FTC) that could have forced it to spin off Instagram and WhatsApp.
1 min
November 20, 2025
Mint Ahmedabad
Fractal Analytics bets heavily on R&D in AI race before IPO
Enterprise artificial intelligence firm Fractal Analytics plans to maintain high research and development (R&D) spending ahead of its market debut for which a date has not yet been set, a top executive has said.
2 mins
November 20, 2025
Mint Ahmedabad
Govt may widen PMJJBY, PMSBY cover
The Centre may allow individuals to raise the insurance cover under the Pradhan Mantri Jeevan Jyoti Bima Yojana (PMJJBY) and Pradhan Mantri Suraksha Bima Yojana (PMSBY) from ₹2 lakh to up to ₹5 lakh by paying a higher premium, according to two people in the know.
1 mins
November 20, 2025
Mint Ahmedabad
Child deaths trigger move to end unlicensed cough syrup sales in villages
India’s apex drug regulator is preparing to tighten rural drug sales by revoking the “household remedy” exemption for cough syrups in villages and remote areas, according to three government officials and a document reviewed by Mint.
2 mins
November 20, 2025
Listen
Translate
Change font size